“The acquisition will reinforce our presence in the dietary food supplement and health ingredient markets and increase our production footprint and capacity in the USA,” stated Antoine Chagnon, CEO of Lallemand. Lallemand currently operates over 45 yeast, bacteria, and fungi production sites across the world, including facilities in the U.S. The acquisition of BIO-CAT provides two additional sites located in the U.S.: Virginia and Minnesota. Explore related questions“When my father, Ed Schuler, and I founded BIO-CAT in 1988, we built the company around family values, science, integrity, and lasting relationships,” stated Chris Schuler. BIO-CAT acknowledged Jefferies LLC and ArentFox Schiff for guiding the company through this process.